Success Metrics

Clinical Success Rate
75.0%

Based on 3 completed trials

Completion Rate
75%(3/4)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Terminated
1(25%)

Phase Distribution

Ph phase_2
1
25%
Ph phase_3
3
75%

Phase Distribution

0

Early Stage

1

Mid Stage

3

Late Stage

Phase Distribution4 total trials
Phase 2Efficacy & side effects
1(25.0%)
Phase 3Large-scale testing
3(75.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

75.0%

3 of 4 finished

Non-Completion Rate

25.0%

1 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Completed(3)
Terminated(1)

Detailed Status

Completed3
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
75.0%
Most Advanced
Phase 3

Trials by Phase

Phase 21 (25.0%)
Phase 33 (75.0%)

Trials by Status

terminated125%
completed375%

Recent Activity

0 active trials
Showing 4 of 4
completedphase_3

A Study With Lidocaine 5% Medicated Plaster in Patients Suffering From Postherpetic Neuralgia

NCT03765697
completedphase_3

A Study With Lido-Patch and Placebo Plaster in Patients Suffering From Postherpetic Neuralgia (PHN)

NCT03745404
terminatedphase_2

Lidocaine 5% Medicated Plaster in Chronic Neuropathic Postoperative Pain

NCT01155986
completedphase_3

Efficacy and Tolerability of Lidocaine Plaster for Treatment of Long-term Local Nerve Pain

NCT01752322

Clinical Trials (4)

Showing 4 of 4 trials
NCT03765697Phase 3

A Study With Lidocaine 5% Medicated Plaster in Patients Suffering From Postherpetic Neuralgia

Completed
NCT03745404Phase 3

A Study With Lido-Patch and Placebo Plaster in Patients Suffering From Postherpetic Neuralgia (PHN)

Completed
NCT01155986Phase 2

Lidocaine 5% Medicated Plaster in Chronic Neuropathic Postoperative Pain

Terminated
NCT01752322Phase 3

Efficacy and Tolerability of Lidocaine Plaster for Treatment of Long-term Local Nerve Pain

Completed

All 4 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
4